Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Replication of the human immunodeficiency virus type 1 is inhibited in human cells with antisense RNA expression.

Sczakiel G, Rittner K, Homann M, Pawlita M.

Biochem Soc Trans. 1991 Nov;19(4):437S. No abstract available.

PMID:
1794555
2.

Inhibition of human immunodeficiency virus type 1 multiplication by antisense and sense RNA expression.

Joshi S, Van Brunschot A, Asad S, van der Elst I, Read SE, Bernstein A.

J Virol. 1991 Oct;65(10):5524-30.

4.

Intracellular expression of antisense RNA transcripts complementary to the human immunodeficiency virus type-1 vif gene inhibits viral replication in infected T-lymphoblastoid cells.

Barnor JS, Miyano-Kurosaki N, Yamaguchi K, Sakamoto A, Ishikawa K, Inagaki Y, Yamamoto N, Osei-Kwasi M, Ofori-Adjei D, Takaku H.

Biochem Biophys Res Commun. 2004 Jul 23;320(2):544-50.

PMID:
15219863
5.
6.
7.

Block of HIV-1 infection by a combination of antisense tat RNA and TAR decoys: a strategy for control of HIV-1.

Chang HK, Gendelman R, Lisziewicz J, Gallo RC, Ensoli B.

Gene Ther. 1994 May;1(3):208-16.

PMID:
7584083
8.

Intracellular expression of RNA transcripts complementary to the human immunodeficiency virus type 1 gag gene inhibits viral replication in human CD4+ lymphocytes.

Veres G, Escaich S, Baker J, Barske C, Kalfoglou C, Ilves H, Kaneshima H, Böhnlein E.

J Virol. 1996 Dec;70(12):8792-800.

9.

Protection of a T-cell line from human immunodeficiency virus replication by the stable expression of a short antisense RNA sequence carried by a shuttle RNA molecule.

Cagnon L, Cucchiarini M, Lefebvre JC, Doglio A.

J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Aug 1;9(4):349-58.

PMID:
7541291
10.
11.

Dual-target inhibition of HIV-1 in vitro by means of an adeno-associated virus antisense vector.

Chatterjee S, Johnson PR, Wong KK Jr.

Science. 1992 Nov 27;258(5087):1485-8.

PMID:
1359646
12.

A new antisense tRNA construct for the genetic treatment of human immunodeficiency virus type 1 infection.

Biasolo MA, Radaelli A, Del Pup L, Franchin E, De Giuli-Morghen C, Palu G.

J Virol. 1996 Apr;70(4):2154-61.

13.

HIV-1-encoded antisense RNA suppresses viral replication for a prolonged period.

Kobayashi-Ishihara M, Yamagishi M, Hara T, Matsuda Y, Takahashi R, Miyake A, Nakano K, Yamochi T, Ishida T, Watanabe T.

Retrovirology. 2012 May 8;9:38. doi: 10.1186/1742-4690-9-38.

14.
16.

Replication of the human immunodeficiency virus type 1 is inhibited by the adeno-associated virus rep gene.

Rittner K, Heilbronn R, Kleinschmidt JA, Oelze I, Sczakiel G.

Biochem Soc Trans. 1991 Nov;19(4):438S. No abstract available.

PMID:
1665443
17.

The middle to 3' end of the HIV-1 vif gene sequence is important for vif biological activity and could be used for antisense oligonucleotide targets.

Barnor JS, Miyano-Kurosaki N, Takaku H, Yamaguchi K, Sakamoto A, Ishikawa K, Yamamoto N, Osei-Kwasi M, Ofori-Adjei D.

Nucleosides Nucleotides Nucleic Acids. 2005;24(10-12):1745-61.

PMID:
16438045
18.

Inhibition of expression of human immunodeficiency virus-1 in vitro by antibody-targeted liposomes containing antisense RNA to the env region.

Renneisen K, Leserman L, Matthes E, Schröder HC, Müller WE.

J Biol Chem. 1990 Sep 25;265(27):16337-42.

19.

Molecular approaches to inhibit HIV-1 tat expression and functions.

Grossi MP, Caputo A, Zucchini S, Bozzini R, Marconi PC, Manservigi R, Barbanti-Brodano G, Balboni PG.

Year Immunol. 1993;7:199-204. No abstract available.

PMID:
8396820
20.

HIV-1 antisense transcription is preferentially activated in primary monocyte-derived cells.

Laverdure S, Gross A, Arpin-André C, Clerc I, Beaumelle B, Barbeau B, Mesnard JM.

J Virol. 2012 Dec;86(24):13785-9. doi: 10.1128/JVI.01723-12. Epub 2012 Oct 3.

Supplemental Content

Support Center